Base Cientifica offers comprehensive molecular and cellular research services to accelerate preclinical development and personalized medicine. They specialize in biological assay validation, biobanking, and molecular diagnostic assay development using PCR and NGS. Their services also include preclinical efficacy and safety studies, 3D organoid cultivation, and AI-driven R&D optimization.
Funding
Funding not disclosed
Founders
Product
Problem
The process of validating biological assays, establishing biobanks, and developing molecular diagnostics is complex and resource-intensive, often requiring specialized infrastructure and expertise. This can create bottlenecks in preclinical research, drug discovery, and the development of personalized medicine approaches.
Solution
Base Cientifica provides advanced molecular biology and cellular research services to streamline preclinical development and facilitate personalized treatment selection. The company specializes in the validation of biological assays, ensuring reproducibility and reliability for drug evaluations and therapeutic applications. They also offer comprehensive biobanking services for the collection, processing, and storage of biological samples, including cell lines and genetic material. Furthermore, Base Cientifica develops and optimizes molecular diagnostic assays using techniques such as PCR and Next-Generation Sequencing (NGS) for pathogen detection and genetic mutation analysis. Their capabilities extend to preclinical efficacy and safety studies, including 3D organoid cultivation and AI-driven R&D optimization, supporting the discovery of novel therapeutic compounds.
Target Audience
Base Cientifica serves clients in the pharmaceutical, biotechnology, and contract research organization (CRO) sectors, as well as hospitals and diagnostic laboratories requiring advanced molecular and cellular research support.
Features
- Biological assay development and validation for drug, diagnostic, and therapeutic applications.
- Biobanking services encompassing collection, processing, and storage of cell lines and genetic material.
- Molecular diagnostic assay development and optimization utilizing PCR and NGS technologies.
- Preclinical efficacy and safety studies, including cell line authentication and functional characterization.
- 3D organoid cultivation for personalized treatment selection and compound screening.
- AI-driven R&D optimization, including workflow automation and multi-omics data analysis.
- Support for preclinical studies of anti-tumor compounds.